AMVIS HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,304 JPY | -3.07% |
|
-2.95% | -23.33% |
| 2023 | Amvis Holdings, Inc. Reports Earnings Results for the Half Year Ended March 31, 2023 | CI |
| 2023 | Amvis Holdings, Inc.(TSE:7071) added to FTSE All-World Index | CI |
ETFs positioned on Amvis Holdings, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.38% | 4 M€ | +1.60% | ||
| 0.71% | 23 M€ | +1.42% | - | |
| 0.02% | 773 M€ | -.--% | - | |
| 0.01% | 73 M€ | +11.61% | ||
| 0.01% | 20,721 M€ | +12.65% | - | |
| 0.01% | 144,586 M€ | +13.76% | ||
| 0.01% | 66,066 M€ | +13.80% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +2.35% | - |
Amvis Holdings, Inc. is mainly engaged in the medical center business. The company's core business is to provide consulting related to the operation and management of residential paid nursing homes, etc., and to rent land and buildings to be used for residential paid nursing homes. The Medical Center business is mainly operated by Amvis, with visiting services such as visiting nursing, visiting care and home care support, as well as residential pay nursing homes. As a business establishment, the Company develop a medical center that meets the wide range of needs of customers such as those who are highly dependent on medical care who have anxiety and concern about their destination after discharge and their families.
Calendar
2024-05-08
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2,377
JPY
Average target price
3,215
JPY
Spread / Average Target
+35.25%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -23.33% | 1.5B | |
| -29.55% | 2.12B | |
| -1.40% | 1.4B | |
| +15.98% | 1.28B | |
| +14.10% | 697M | |
| -3.64% | 459M | |
| +231.78% | 400M | |
| -8.71% | 325M | |
| -2.84% | 113M | |
| +39.36% | 87M |
- Stock Market
- Equities
- 7071 Stock
- Funds and ETFs Amvis Holdings, Inc.
